Sofosbuvir + Velpatasvir + Voxilaprevir

Category: Hepatitis

Voxilaprevir is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor (by Gilead) that is used in combination with sofosbuvir and velpatasvir.[2] The combination has the trade name Vosevi and received a positive opinion from the European Committee for Medicinal Products for Human Use in June 2017.[3] On 18 July 2017, Vosevi was approved by the US Food and Drug Administration.[4] References .mw-parser-output .reflist{fon... [wikipedia]

Related Brands

Drugs with the same active ingredients

Popular Topics

Which is the efficiency of the Ledipasvir + Sofosbuvir?

Please, be so kind and tell me if you have some reference about "LEDVIR", do you think that this medicine could ...